Preferential Susceptibility of Brain Tumors to the Antiangiogenic Effects of an αv Integrin Antagonist
- 1 January 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 48 (1) , 151-157
- https://doi.org/10.1097/00006123-200101000-00026
Abstract
OBJECTIVE. Brain tumors are highly angiogenic, and their growth and spread depend on the generation of new blood vessels. We examined the effect of theKeywords
This publication has 41 references indexed in Scilit:
- Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv IntegrinsCell, 1998
- Expression of Vascular Endothelial Growth Factor and Its Receptors in the Anaplastic Progression of Astrocytoma, Oligodendroglioma, and EpendymomaThe American Journal of Surgical Pathology, 1998
- Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytomaJournal of Neurosurgery, 1998
- Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor.Proceedings of the National Academy of Sciences, 1996
- Definition of Two Angiogenic Pathways by Distinct α v IntegrinsScience, 1995
- Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.Journal of Clinical Investigation, 1995
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Immunolocalization of basic fibroblast growth factor to the micro vasculature of human brain tumorsCancer, 1992
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989